CorMedix Inc.
CRMD
$12.08
$0.585.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.83M | 20.64M | 13.46M | -2.78M | -14.15M |
| Total Depreciation and Amortization | 162.90K | 161.90K | 133.70K | 77.40K | 76.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.71M | 3.55M | 1.37M | 1.26M | 1.30M |
| Change in Net Operating Assets | 7.29M | -4.62M | -20.58M | -12.22M | -1.27M |
| Cash from Operations | 29.99M | 19.74M | -5.61M | -13.65M | -14.04M |
| Capital Expenditure | -23.90K | -10.20K | -9.90K | -9.80K | -34.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.19M | -184.60K | -294.30K | 6.33M | 6.30M |
| Cash from Investing | -20.21M | -194.80K | -304.20K | 6.32M | 6.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 83.49M | 7.11M | 11.34M | 14.07M | 1.20M |
| Repurchase of Common Stock | -247.50K | -1.02M | -53.00K | 0.00 | -139.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 83.24M | 6.09M | 11.28M | 14.07M | 1.06M |
| Foreign Exchange rate Adjustments | 800.00 | 200.00 | -1.20K | 400.00 | -100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.02M | 25.63M | 5.36M | 6.75M | -6.71M |